2016 Q1 Form 10-Q Financial Statement

#000114420416101925 Filed on May 13, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015 Q1
Revenue $9.125K $200.0K $184.9K
YoY Change -95.06% 150.0% 49207.2%
Cost Of Revenue $10.00 $60.00K $76.43K
YoY Change -99.99% -45.45% 127286.67%
Gross Profit $9.115K $140.0K $108.5K
YoY Change -91.6% -566.67% 34334.92%
Gross Profit Margin 99.89% 70.0% 58.66%
Selling, General & Admin $1.210M $2.300M $1.330M
YoY Change -9.02% 144.68% 43.01%
% of Gross Profit 13274.82% 1642.86% 1226.15%
Research & Development $866.0K $630.0K $406.9K
YoY Change 112.86% 80.0% -17.6%
% of Gross Profit 9501.31% 450.0% 375.09%
Depreciation & Amortization $62.39K $60.00K $39.61K
YoY Change 57.5% 100.0% 55.24%
% of Gross Profit 684.5% 42.86% 36.52%
Operating Expenses $2.076M $2.930M $1.734M
YoY Change 19.71% 127.13% 21.4%
Operating Profit -$2.067M -$2.790M -$1.626M
YoY Change 27.13% 111.36% 13.83%
Interest Expense $42.84K -$220.0K $64.64K
YoY Change -33.73% 46.67% -11.61%
% of Operating Profit
Other Income/Expense, Net -$420.2K -$100.0K -$134.2K
YoY Change 213.22% 400.0% -44.39%
Pretax Income -$2.490M -$3.120M -$1.760M
YoY Change 41.48% 110.81% 5.39%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.487M -$3.120M -$1.760M
YoY Change 41.32% 110.81% 5.42%
Net Earnings / Revenue -27258.39% -1560.0% -951.92%
Basic Earnings Per Share
Diluted Earnings Per Share -$687.8K -$1.016M -$1.000M
COMMON SHARES
Basic Shares Outstanding 3.926M shares 37.15M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $350.0K $170.0K $150.0K
YoY Change 133.33% 88.89% 36.36%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $20.00K $30.00K $30.00K
YoY Change -33.33% 50.0% 200.0%
Inventory $1.927K
Prepaid Expenses
Receivables $9.000K $93.38K $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $384.2K $289.3K $180.2K
YoY Change 113.15% 153.06% 31.25%
LONG-TERM ASSETS
Property, Plant & Equipment $599.4K $643.1K $537.2K
YoY Change 11.59% 30.22% 2005.25%
Goodwill
YoY Change
Intangibles $1.020M $1.039M $1.095M
YoY Change -6.84% 0.1% 0.44%
Long-Term Investments
YoY Change
Other Assets $50.00K $50.00K $50.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $1.665M $1.728M $1.678M
YoY Change -0.75% 9.52% 50.41%
TOTAL ASSETS
Total Short-Term Assets $384.2K $289.3K $180.2K
Total Long-Term Assets $1.665M $1.728M $1.678M
Total Assets $2.049M $2.017M $1.858M
YoY Change 10.29% 19.22% 48.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.194M $2.549M $1.266M
YoY Change 73.37% 129.26% 5.19%
Accrued Expenses $2.045M $2.047M $1.885M
YoY Change 8.49% 39.57% 46.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.320M $1.010M $5.460M
YoY Change -75.82% -82.25% 5.2%
Total Short-Term Liabilities $5.590M $5.612M $8.922M
YoY Change -37.35% -34.16% 12.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $300.0K $310.0K
YoY Change -100.0% 500.0% 10.71%
Other Long-Term Liabilities $0.00 $10.00K $20.00K
YoY Change -100.0% 0.0% -33.33%
Total Long-Term Liabilities $0.00 $310.0K $330.0K
YoY Change -100.0% 416.67% 6.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.590M $5.612M $8.922M
Total Long-Term Liabilities $0.00 $310.0K $330.0K
Total Liabilities $5.590M $5.925M $9.250M
YoY Change -39.57% -30.94% 12.31%
SHAREHOLDERS EQUITY
Retained Earnings -$35.81M -$33.32M -$27.16M
YoY Change 31.85% 31.19%
Common Stock $3.959K $3.339K
YoY Change 93.45%
Preferred Stock
YoY Change
Treasury Stock (at cost) $32.00K $32.00K
YoY Change 0.0%
Treasury Stock Shares 27.93K shares 27.93K shares 558.6K shares
Shareholders Equity -$3.541M -$3.908M -$7.400M
YoY Change
Total Liabilities & Shareholders Equity $2.049M $2.017M $1.860M
YoY Change 10.19% 19.22% 48.45%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015 Q1
OPERATING ACTIVITIES
Net Income -$2.487M -$3.120M -$1.760M
YoY Change 41.32% 110.81% 5.42%
Depreciation, Depletion And Amortization $62.39K $60.00K $39.61K
YoY Change 57.5% 100.0% 55.24%
Cash From Operating Activities -$1.720M -$1.050M -$670.0K
YoY Change 156.72% 64.06% -16.95%
INVESTING ACTIVITIES
Capital Expenditures $89.87K -$50.00K $92.17K
YoY Change -2.5% -70.59%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$80.00K
YoY Change -100.0%
Cash From Investing Activities -$90.00K -$40.00K -$170.0K
YoY Change -47.06% -76.47% -17446.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.990M 1.260M 900.0K
YoY Change 121.11% 142.31% 25.87%
NET CHANGE
Cash From Operating Activities -1.720M -1.050M -670.0K
Cash From Investing Activities -90.00K -40.00K -170.0K
Cash From Financing Activities 1.990M 1.260M 900.0K
Net Change In Cash 180.0K 170.0K 60.00K
YoY Change 200.0% -158.62% -166.12%
FREE CASH FLOW
Cash From Operating Activities -$1.720M -$1.050M -$670.0K
Capital Expenditures $89.87K -$50.00K $92.17K
Free Cash Flow -$1.810M -$1.000M -$762.2K
YoY Change 137.46% 112.77% -5.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22060 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29348 USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
384155 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
289278 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
599419 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
643087 USD
CY2016Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1020017 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1038741 USD
CY2016Q1 us-gaap Assets
Assets
2049491 USD
CY2015Q4 us-gaap Assets
Assets
2017006 USD
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2194086 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2549042 USD
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2044649 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2046795 USD
CY2016Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
34586 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6823 USD
CY2016Q1 us-gaap Notes Payable Current
NotesPayableCurrent
1316780 USD
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1009797 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5590101 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5612457 USD
CY2016Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
0 USD
CY2015Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
11011 USD
CY2016Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2015Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
302001 USD
CY2016Q1 us-gaap Liabilities
Liabilities
5590101 USD
CY2015Q4 us-gaap Liabilities
Liabilities
5925469 USD
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
3959 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
3339 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
76432 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
9115 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
108470 USD
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32298265 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29443704 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35810834 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33323506 USD
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
32000 USD
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
32000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
-3540610 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-3908463 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2049491 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2017006 USD
CY2016Q1 us-gaap Security Deposit
SecurityDeposit
45900 USD
CY2015Q4 us-gaap Security Deposit
SecurityDeposit
45900 USD
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
93375 USD
CY2016Q1 us-gaap Revenues
Revenues
9125 USD
CY2015Q1 us-gaap Revenues
Revenues
184902 USD
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
10 USD
CY2016Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
22517 USD
CY2015Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
44937 USD
CY2016Q1 us-gaap Professional Fees
ProfessionalFees
284807 USD
CY2015Q1 us-gaap Professional Fees
ProfessionalFees
365069 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
866044 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
406856 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
902881 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
917574 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
2076249 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
1734436 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2067134 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1625966 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
42840 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
64640 USD
CY2016Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
337021 USD
CY2015Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
69515 USD
CY2016Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-11847 USD
CY2015Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2016Q1 brtx Warrant Modification Expense
WarrantModificationExpense
28486 USD
CY2015Q1 brtx Warrant Modification Expense
WarrantModificationExpense
0 USD
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-420194 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-134155 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-2487328 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-1760121 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.00
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3619813 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1755398 shares
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39613 USD
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62392 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
371167 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
411618 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11850 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7288 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
80534 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-265091 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
489831 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
88641 USD
CY2015Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1085343 USD
CY2016Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
769493 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-674778 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1717835 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92169 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
89865 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-167169 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-89865 USD
CY2015Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
30000 USD
CY2016Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
325000 USD
CY2015Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2016Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
103500 USD
CY2015Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
125070 USD
CY2016Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
46030 USD
CY2015Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
60055 USD
CY2016Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
104560 USD
CY2015Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2016Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
212898 USD
CY2015Q1 brtx Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
801000 USD
CY2016Q1 brtx Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
1618372 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
896015 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1994240 USD
CY2015Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
54068 USD
CY2016Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
186540 USD
CY2014Q4 us-gaap Cash
Cash
91798 USD
CY2015Q1 us-gaap Cash
Cash
145866 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
46533 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2016Q1 brtx Payments To License Maintenance Costs
PaymentsToLicenseMaintenanceCosts
0 USD
CY2015Q1 brtx Payments To License Maintenance Costs
PaymentsToLicenseMaintenanceCosts
75000 USD
CY2016Q1 us-gaap Accretion Expense
AccretionExpense
2916 USD
CY2015Q1 us-gaap Accretion Expense
AccretionExpense
0 USD
CY2016Q1 brtx Warrant Modification Extension Expense
WarrantModificationExtensionExpense
28486 USD
CY2015Q1 brtx Warrant Modification Extension Expense
WarrantModificationExtensionExpense
0 USD
CY2016Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 USD
CY2015Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-84375 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
10000 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
36540 USD
CY2016Q1 brtx Conversion Of Notes Payable And Accruedinterest In To Common Stock
ConversionOfNotesPayableAndAccruedinterestInToCommonStock
157370 USD
CY2015Q1 brtx Conversion Of Notes Payable And Accruedinterest In To Common Stock
ConversionOfNotesPayableAndAccruedinterestInToCommonStock
55984 USD
CY2016Q1 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
215446 USD
CY2015Q1 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
10690 USD
CY2016Q1 brtx Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
0 USD
CY2015Q1 brtx Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
64276 USD
CY2015Q3 brtx Stockholders Equity Note Changes In Capital Structure Retroactive Impact Shares
StockholdersEquityNoteChangesInCapitalStructureRetroactiveImpactShares
200000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2016Q1 brtx Working Capital Net
WorkingCapitalNet
5205946 USD
CY2016Q1 brtx Proceeds From Equity Financing
ProceedsFromEquityFinancing
225000 USD
CY2016Q1 brtx Proceeds From Debt Financing
ProceedsFromDebtFinancing
155000 USD
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1298117 shares
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3688953 shares
CY2016Q1 brtx Credit Card Payable Current
CreditCardPayableCurrent
2737 USD
CY2015Q4 brtx Credit Card Payable Current
CreditCardPayableCurrent
3171 USD
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
984287 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1010633 USD
CY2016Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
43455 USD
CY2015Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
43604 USD
CY2016Q1 brtx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
476175 USD
CY2015Q4 brtx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
446175 USD
CY2016Q1 brtx Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
509495 USD
CY2015Q4 brtx Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
456182 USD
CY2016Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
28500 USD
CY2015Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
87030 USD
CY2016Q1 brtx Exchanges For Equity
ExchangesForEquity
160000 USD
CY2016Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
150000 USD
CY2015Q4 us-gaap Notes Payable
NotesPayable
1311798 USD
CY2016Q1 us-gaap Notes Payable
NotesPayable
1316780 USD
CY2016Q1 brtx Note Payable Principal Issued
NotePayablePrincipalIssued
325000 USD
CY2016Q1 brtx Recognition Of Debt Discount
RecognitionOfDebtDiscount
246455 USD
CY2016Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
33000 USD
CY2015Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
35000 USD
CY2016Q1 brtx Warrants Aggregate Grant Date Fair Value
WarrantsAggregateGrantDateFairValue
1127283 USD
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 brtx Debt Instrument Unamortized Debt Discount Current Portion
DebtInstrumentUnamortizedDebtDiscountCurrentPortion
64803 USD
CY2015Q4 brtx Debt Instrument Unamortized Debt Discount Current Portion
DebtInstrumentUnamortizedDebtDiscountCurrentPortion
150286 USD
CY2016Q1 brtx Debt Instrument Unamortized Debt Discount Noncurrent Portion
DebtInstrumentUnamortizedDebtDiscountNoncurrentPortion
0 USD
CY2015Q4 brtx Debt Instrument Unamortized Debt Discount Noncurrent Portion
DebtInstrumentUnamortizedDebtDiscountNoncurrentPortion
7999 USD
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3958750 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3338661 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3930818 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3310729 shares
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
27932 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
27932 shares
CY2016Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1618372 USD
CY2016Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
157370 USD
CY2016Q1 brtx Shares Issued In Satisfaction Of Accrued Interest
SharesIssuedInSatisfactionOfAccruedInterest
2333 USD
CY2016Q1 brtx Adjustments To Additional Paid In Capital Shares And Warrants Issued As Debt Discount Value
AdjustmentsToAdditionalPaidInCapitalSharesAndWarrantsIssuedAsDebtDiscountValue
31009 USD
CY2016Q1 brtx Stocks And Warrants Issued During Period Value In Exchange Of Debt
StocksAndWarrantsIssuedDuringPeriodValueInExchangeOfDebt
177649 USD
CY2016Q1 brtx Warrant Modification Charge
WarrantModificationCharge
28486 USD
CY2016Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50624 USD
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
360994 USD
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> </div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the periods. The Company&#8217;s significant estimates and assumptions include the recoverability and useful lives of long-lived assets, the fair value of the Company&#8217;s stock, stock-based compensation, warrants issued in connection with notes payable and the valuation allowance related to the Company&#8217;s deferred tax assets. Certain of the Company&#8217;s estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company&#8217;s estimates and could cause actual results to differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> </div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Concentrations and Credit Risk</font></u></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Two pharmaceutical clients comprised substantially all of the Company&#8217;s revenue during the three months ended March 31, 2015. See Revenue Recognition &#150; Research and Development Agreements below.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company implemented a 1-for-20 reverse split
CY2016Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
75000 USD
CY2016Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.1 pure
CY2016Q1 brtx Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
1248937 shares
CY2016Q1 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
56000 USD
CY2016Q1 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
5000 USD
CY2016Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
188000 USD
CY2016Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000 USD
CY2016Q1 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
25000 USD
CY2016Q1 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
5000 USD
CY2016Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
163000 USD
CY2016Q1 brtx Debt Instrument Conversion Period Description
DebtInstrumentConversionPeriodDescription
(a) 62% of the fair market value of the Companys stock or (b) $2.00 per share. Should the Company elect to convert any of the note principal and respective accrued interest, the holder will have the right to accelerate the conversion of the remaining outstanding principal and accrued interest of the note.
CY2016Q1 brtx Notes Payable Aggregate Principal Past Due
NotesPayableAggregatePrincipalPastDue
346518 USD

Files In Submission

Name View Source Status
0001144204-16-101925-index-headers.html Edgar Link pending
0001144204-16-101925-index.html Edgar Link pending
0001144204-16-101925.txt Edgar Link pending
0001144204-16-101925-xbrl.zip Edgar Link pending
brtx-20160331.xml Edgar Link completed
brtx-20160331.xsd Edgar Link pending
brtx-20160331_cal.xml Edgar Link unprocessable
brtx-20160331_def.xml Edgar Link unprocessable
brtx-20160331_lab.xml Edgar Link unprocessable
brtx-20160331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v438919_10q.htm Edgar Link pending
v438919_ex31-1.htm Edgar Link pending
v438919_ex31-2.htm Edgar Link pending
v438919_ex32.htm Edgar Link pending